OP
WST icon

ORG Partners’s West Pharmaceutical WST Stock Holding History

ORG Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.53K Hold
31
– – ﹤0.01% 1057
2025
Q3 		$8.13K Buy
31
+7
+29% +$1.7K ﹤0.01% 1017
2025
Q2 		$5.34K Sell
24
-30
-56% -$6.41K ﹤0.01% 1043
2025
Q1 		$65.4K Sell
54
-211
-80% -$58.2K 0.02% 445
2024
Q4 		$86.8K Buy
265
+4
+2% +$1.26K 0.01% 453
2024
Q3 		$78.3K Sell
261
-308
-54% -$94.3K 0.01% 434
2024
Q2 		$185K Buy
569
+431
+312% +$152K 0.02% 447
2024
Q1 		$54.6K Buy
138
+123
+820% +$45.5K 0.1% 127
2023
Q4 		$5.33K Sell
15
-1,421
-99% -$503K ﹤0.01% 839
2023
Q3 		$539K Sell
1,436
-201
-12% -$77.7K 0.16% 148
2023
Q2 		$624K Buy
+1,637
New +$585K 0.1% 182

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return